Yahoo Web Search

Search results

    • Q1 2024 Gilead Sciences Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 days ago

      Total product sales, excluding Veklury, grew 6% year-over-year to $6.1 billion, driven by higher demand across HIV, oncology and liver disease. Veklury sales continue to track with the rates ...

    • The Eastern Company Declares 335th Consecutive Quarterly Cash Dividend

      Digital Journal· 2 days ago

      ...inability to achieve the savings expected from global sourcing of materials; lower-cost competition; our ability to design, introduce and sell new or updated products and related components; market acceptance of our products; the inability to attain expected benefits from acquisitions or the...

    • Q1 2024 Thermo Fisher Scientific Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 3 days ago

      Finally, in Diagnostics and Healthcare in Q1, we declined in the high single digits. The reported growth in this end market was impacted by the runoff of COVID-19& ...